Navigation Links
AMP comments at FDA meeting on array-based tests

Bethesda, MD (June 30, 2010): Today, the Association for Molecular Pathology (AMP) presented comments at the US Food & Drug Administration's public meeting on array-based cytogenetic tests. The FDA convened the meeting to seek answers to more than a dozen questions they had on how to evaluate the performance, interpret results and report findings of array-based cytogenetic tests for copy number variation (CNV).

AMP believes array-based cytogenetic tests provide much higher resolution than traditional karyotyping, with expansive capabilities to diagnose and identify causes of genetic syndromes due to chromosome abnormalities. The standard of care in molecular and cytogenetic laboratories as well as genetics clinics is shifting from traditional karyotyping to array-based cytogenomic analysis. "This new technology has provided diagnoses that would have otherwise not been possible with older methods," explained Dr. Mark Sobel, AMP Executive Director.

Professional societies, such as AMP, are currently working to develop professional practice guidelines to address many of the questions raised by the FDA that focus on interpreting and reporting results of array-based cytogenetic tests. AMP believes that the interpretation of these tests falls within the scope of professional practice and that while the FDA should evaluate the technology platform for analytical validity, the FDA does not need to review each possible CNV result. "It is important to remember that all testing is performed in the context of the phenotype of the patient, and interpretation of laboratory data is a collaboration between the clinical scientist and the treating physician," said Dr. Sobel. AMP encourages the FDA to partner with professional associations to collaborate on the best manner to standardize the use and reporting of array-based tests.

AMP believes that to advance the use of array-based cytogenetic tests, the molecular cytogenetic field needs to collect data on both the laboratory results and clinical information. Dr. Sobel added, "Such a database will enable the community to continually assess the validity of results and accelerate the understanding of the results." AMP encourages the government to fund clinical research to further explore the associations between array findings and health information.


Contact: Mary Steele Williams
Association for Molecular Pathology

Related biology news :

1. AVAC comments on NIAID decision not to move forward with PAVE 100 Trial
2. Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial
3. AMP submits comments on SACGHS report
4. Society for General Microbiology 161st Meeting, University of Edinburgh
5. Planetary geoscience, paleontology, and more at GSA Annual Meeting in Denver next month
6. Colony collapse disorder symposium added to ESA Annual Meeting
7. Meeting real-world climate information needs of business, government
8. Food and environmental sustainability focus of ASA-CSSA-SSSA Annual Meetings
9. NAS Biodiversity and Extinction Meeting Dec. 7-8
10. HGS announces positive Phase 2 LymphoStat-B at ACR meeting
11. New studies on schizophrenia, depression, trauma and autism highlight annual meeting
Post Your Comments:
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a ... that it has released a new version of its ... in North America have already ... v4.0 also includes a FIDO UAF certified server ... already preparing to activate FIDO features. These customers include ...
(Date:10/29/2015)... 29, 2015  Connected health pioneer, Joseph C. ... of technology-enabled health and wellness, and the business opportunities ... The Internet of Healthy Things . Long ... even existed, Dr. Kvedar, vice president, Connected Health, Partners ... delivery, moving care from the hospital or doctor,s office ...
(Date:10/29/2015)... 2015 Today, LifeBEAM , a ... 2XU, a global leader in technical performance sports ... with advanced bio-sensing technology. The hat will allow ... key biometrics to improve overall training performance. As ... will bring together the most advanced technology, extensive ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) ... research organisation (CRO) market. The trend of outsourcing ... lower margins but higher volume share for the ... and scale, however, margins in the CRO industry ... (CRO) Market ( ), finds that ...
(Date:11/24/2015)... 24, 2015 Cepheid (NASDAQ: CPHD ) ... the following conference, and invited investors to participate via ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ... New York, NY      Tuesday, December 1, ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
Breaking Biology Technology: